Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human E-Cadherin Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB18382SP
This item is not returnable.
View return policy
Description
E-Cadherin Monoclonal specifically detects E-Cadherin in Human samples. It is validated for Western Blot.Specifications
E-Cadherin | |
Monoclonal | |
LYOPH | |
Western Blot 2 ug/mL | |
P12830 | |
CDH1 | |
Mouse myeloma cell line NS0-derived recombinant human E-Cadherin Asp155-Ile707 Accession # P12830 | |
25 μg | |
Primary | |
Detects human E-Cadherin in ELISAs and Western blots. In Western blots, this antibody does not cross-react with recombinant human (rh) Cadherin-8, rhCadherin-17, recombinant mouse E-Cadherin, rhP-Cadherin, or rhVE-Cadherin. | |
Human | |
Purified |
Western Blot | |
77308 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
Arc-1, CAD1, cadherin 1, E-cadherin (epithelial), cadherin 1, type 1, E-cadherin (epithelial), cadherin-1, calcium-dependent adhesion protein, epithelial, CAM 120/80, CD324, CD324 antigen, CDH1, CDHE, cell-CAM 120/80, Cell-CAM120/80, ECAD, E-cadherin, ECadherin, Epithelial cadherin, LCAM, L-CAM, UVOE-Cadherin, uvomorulin | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
999 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction